PIETRO CAVATAIO: Open Payments
NPI 1871569798 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,846 in 58 payments from 18 companies in 2025. Trend: 2023 $494 · 2024 $733 · 2025 $1,846
Food & beverage: $1,846
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $610 |
| ABBVIE INC. | 11 | $407 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $216 |
| PFIZER INC. | 1 | $125 |
| Novo Nordisk Inc | 5 | $102 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Alkermes, Inc. | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
Products named: AIRSUPRA, CAPLYTA, BREZTRI, VRAYLAR, QULIPTA, NURTEC ODT, MAVYRET, Auvelity.
Industry payments across MI — which companies pay providers there.
